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Abstract: To date, mesenchymal stem cells (MSCs) from various tissues have been reported, but the yield and differentia-
tion potential of different tissue-derived MSCs is still not clear. This study was undertaken in an attempt to investigate the 
multilineage stem cell potential of bone and cartilage explant cultures in comparison with bone marrow derived mesen-
chymal stem cells (BMSCs). The results showed that the surface antigen expression of tissue-derived cells was consistent 
with that of mesenchymal stem cells, such as lacking the hematopoietic and common leukocyte markers (CD34, CD45) 
while expressing markers related to adhesion (CD29, CD166) and stem cells (CD90, CD105). The tissue-derived cells 
were able to differentiate into osteoblast, chondrocyte and adipocyte lineage pathways when stimulated in the appropriate 
differentiating conditions. However, compared with BMSCs, tissue-derived cells showed less capacity for multilineage 
differentiation when the level of differentiation was assessed in monolayer culture by analysing the expression of tissue-
specific genes by reverse transcription polymerase chain reaction (RT-PCR) and histology. In high density pellet cultures, 
tissue-derived cells were able to differentiate into chondrocytes, expressing chondrocyte markers such as proteoglycans, 
type II collagen and aggrecan. Taken together, these results indicate that cells derived from tissue explant cultures re-
served certain degree of differentiation properties of MSCs in vitro.  
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INTRODUCTION  
 Multipotent mesenchymal stem cells (MSCs) provide a 
fascinating model of differentiation [1, 2], as well as a prom-
ising tool for cell therapy and treatment of a range of degen-
erative diseases [3, 4]. MSCs are considered to be quiescent, 
lacking tissue-specific characteristics and maintain this un-
differentiated phenotype until they are exposed to appropri-
ate signals [5, 6]. MSCs have a capacity for extensive self 
renewal and maintain themselves throughout the life of an 
organism. They are “plastic” and under the influence of spe-
cific biological signals differentiate into specialized cells 
with a phenotype that is completely different from that of the 
precursor [5, 7]. It is this property that MSCs can be ex-
ploited in multiple tissue repair and regeneration through 
therapeutic cell delivery. 
 Human bone marrow primarily serves as a reservoir for 
different populations of stem cells. It contains at least two 
types of stem cells: hematopoietic stem cells and mesenchy-
mal stem cells (BMSCs) [8-16]. Despite the fact that bone 
marrow represents the main available source of MSCs, 
MSCs have been recently identified in numerous other mes-
enchymal tissues including trabecular bone [17-20], pe-
riosteum [21-24], adipose tissue [25-27], synovium [28, 29], 
skeletal muscle [30], lung [31] and deciduous teeth [32]. 
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These tissue-derived cells have the capacity to differentiate 
into connective tissue cell lineages, including bone, fat, carti-
lage and muscle when placed in appropriate environments in 
vitro and in vivo [11, 33-37]. However, it’s impossible to 
draw a definite conclusion regarding the differentiation po-
tential of tissue-derived cells due to the different methods 
used for cell isolation. Even though there is no specific cell 
surface marker for MSCs, a number of studies selected cell 
populations from tissue cultures based on the expression of 
Stro-1, CD105 and CD 106 [38, 39]. Therefore, the current 
study was undertaken in an attempt to compare the multi-
lineage stem cell potential of tissue explant cultures of bone 
and cartilage. Bone marrow-derived MSCs (BMSCs) were 
used as a control and the cells derived from tissue explants 
of trabecular bone (hOB), cartilage (YCC) and alveolar bone 
(OBM) tissues were investigated side-by-side as sources of 
MSCs. Our studies revealed that MSCs isolated from tissue 
explant cultures had the potential to differentiate into multi-
ple lineages, thereby indicating that these tissues may be 
alternative sources of mesenchymal stem cells via explant 
culture. 
MATERIALS AND METHODS 
Isolation and Culture of Bone Marrow-Derived MSCs 
 Fresh bone marrow samples (n=7, aged 65-70 years old) 
were collected by aspiration from femoral canal during knee 
replacement operation at the Holy Spirit Northside Hospital, 
Brisbane QLD, Australia, in accordance with the institu- 
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tional review board guidelines approved by the human re-
search ethics committees of the Queensland University of 
Technology, The Prince Charles and The Holy Spirit Private 
Hospitals, Brisbane, QLD, Australia. After draining of syno-
vial fluid, a femoral drill hole was made through the distal 
femur and an intramedullary rod was passed into the femoral 
canal. Marrow aspirates were collected by syringe. Mononu-
clear cells, which include the MSC population, were har-
vested using LymphoPrep® density gradient centrifugation. 
Briefly, 2-5 ml of bone marrow was collected in a 50 ml tube 
containing 5 ml phosphate buffered saline (PBS) supple-
mented with 200 U/ml Heparin (Invitrogen, Mount Waver-
ley, VIC, Australia). Each sample was filtered through a 100 
m filter and 30 ml PBS was added to the filtrate. The di-
luted cell suspension was carefully layered below Lym-
phoPrep® and was then centrifuged for 35 minutes at 400 g, 
at 20 ºC without braking. The upper layer was aspirated leav-
ing the mononuclear cell layer undisturbed at the interphase. 
The MSC-enriched low density fraction was collected care-
fully and rinsed with 20 ml of control medium containing 
low glucose (LG; 1g/l glucose) Dulbecco’s-Modified Eagles 
Media (DMEM; Invitrogen) with 10% fetal bovine serum 
(FBS; HyClone, Logan, Utah, USA), 10 U/ml penicillin and 
10 μg/ml streptomycin (Invitrogen) by centrifugation at 200 
g for 10 minutes at 20 ºC. The resulting cell pellet was re-
suspended in DMEM and plated at 8 x 105 nucleated 
cells/T25 cm2 tissue culture flasks. MSC cultures were main-
tained at 37 ºC in 5% CO2, for 6 days before the medium 
was changed and thereafter the medium was changed every 
three days. When the cultures were 80-90% confluent, the 
cells were detached using 0.05% Trypsin-EDTA (Invitrogen) 
and replated at a density of 1.28 x 105 cells/T75 flask (termed 
passage 1) in low glucose DMEM containing 10% FBS and 
Penicillin/Streptomycin. When the MSC cultures were 80-
90% confluent they were replated at a ratio of 1:3 for expan-
sion under the same culture conditions and cryo-preserved in 
liquid nitrogen for later analysis. 
Isolation of Trabecular Bone and Cartilage-Derived Cells 
 Samples of trabecular bone (hOB) and cartilage (YCC) 
(n=7, aged 65-70 years old) from the relatively healthy part 
of tibia of the same patients of marrow collection were ob-
tained. Normal human alveolar bone specimens (OBM) 
(n=5) were obtained from young, healthy patients aged from 
12-16 years old at orthodontic clinic with ethics approval 
from the University of Queensland. Bone and cartilage 
pieces were cut into fragments of size 3-8 mm, cleaned of 
adherent connective tissue, rinsed well and placed directly 
into six-well culture plates containing high glucose (HG; 
4.5g/l glucose) DMEM (Invitrogen) supplemented with 10% 
FCS (HyClone), 10 U/ml penicillin and 10 μg/ml streptomy-
cin (Invitrogen). Confluent monolayers of fibroblast-like 
cells were obtained after 10-20 days and were passaged once 
in 25 cm2 flasks until confluent. The cells were then cryopre-
served for later analysis. All cultures from individual donors 
were maintained separately. 
FACS Analysis 
 Analysis of cell surface molecules was performed follow-
ing the procedure reported by Pittenger [14] and Majumdar 
[40]. Briefly cells (passage 5) were trypsinized, washed with  
 
PBS and in FACS buffer (2% BSA, 0.1% sodium azide in 
PBS) and aliquots of cells (1 X 106) were incubated at 4 oC 
for 30 minutes with antibodies against CD29, CD34, CD45, 
CD90, CD105 and CD166 (BD Biosciences, North Ryde, 
NSW, Australia). Subsequently, secondary antibody IgG1 
(fluorochrome-conjugated) was added and incubated at room 
temperature for 15 minutes. Analysis of the cell surface anti-
gens was performed with a FACS Calibur Cytometer (BD 
Biosciences, San Jose, CA, USA). Controls for the FACS 
procedures included conditions where the primary antibody 
was omitted. In addition, an anti- human IgG1 antibody (BD 
Biosciences) was used. 
Osteogenic, Chondrogenic and Adipogenic Differentiation 
 Differentiation experiments were performed on cultures 
recovered from frozen stocks at passages 2-6. The cells were 
grown to confluence and then subjected to specific differen-
tiating conditions as described below. The differentiation 
assay was carried out in triplicate in six-well culture plates 
with all samples of BMSCs (n=7), hOB (n=7), YCC (n=7) 
and OBM (n=5).  
Osteogenic Differentiation 
 Osteogenic differentiation of subconfluent MSCs from 
bone marrow and explant tissue-derived monolayers was 
induced by transfer to high glucose DMEM (HG DMEM) 
medium containing 10% FBS, 50 M ascorbic acid 2-
phosphate, 10 mM -glycerol phosphate and 100 nM dex-
amethasone (Sigma Aldrich, Castle Hill, NSW, Australia) in 
HG DMEM. After four weeks, calcium phosphate mineral 
deposition was visualized by von Kossa staining. 
Chondrogenic Differentiation 
 Chondrogenic medium consists of serum-free medium 
consisting of HG DMEM supplemented with 10 ng/ml TGF–
3 (Chemicon, Boronia, VIC, Australia), 100 nM dex-
amethasone (Sigma Aldrich), 50 g/ml ascorbic acid 2-
phosphate (Sigma Aldrich), 100 g/ml sodium pyruvate (In-
vitrogen), 40 g/ml proline (Sigma Aldrich) and ITS-plus 
(BD Biosciences; final concentrations: 6.25 g/ml insulin, 
6.25 g/ml transferrin, 6.25 g/ml selenous acid, 5.33 g/ml 
linoleic acid and 1.25 mg/ml bovine serum albumin). After 
four weeks, the differentiated monolayers were stained with 
Alcian Blue (Sigma Aldrich) for visualization of proteogly-
can deposition. 
 Cells were also cultured as a micromass pellet of cells, 
created by gentle centrifugation [36]. To initiate the chon-
drogenic culture, aliquots of 5 x 105 cells were suspended in 
0.5 ml of chondrogenic media with TGF–3 (with the rest of 
the supplements described above) and centrifuged at 600g 
for 5 mins in a 15 ml polypropylene conical tube. The cells 
were left at the bottom of the tube and placed in a 37 oC CO2 
incubator with loosened caps permitting gas exchange. The 
medium was replaced three times a week. After 3 weeks the 
cell pellets were washed in PBS, fixed in 4% paraformalde-
hyde and embedded in paraffin. The pellets were sectioned 
(5 m thickness) and analyzed for the expression of proteo-
glycans using Alcian Blue stain. Immunohistochemical stud-
ies were carried out on the pellet sections to detect chondro-
cyte specific proteins such as aggrecan (AGG) and type II 
collagen (Col-II). 
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Adipogenic Differentiation 
 Cells from passages 2-6 were treated for 3 days with adi-
pogenic induction medium containing 0.5 mM isobu-
tylmethyl xanthine (Sigma Aldrich), 100-200 M indo-
methacin (Sigma Aldrich), 1 M dexamethasone, 10 g/ml 
insulin (Invitrogen) in HG DMEM with 10% FBS, and then 
the medium was changed to adipogenic maintenance me-
dium (HG DMEM with FBS and insulin) for 24 hrs. After 
the three cycle schedule of 3 days in inducing medium and 1 
day in maintenance medium, cells were grown in adipogenic 
maintenance medium for another 7 days, with the change of 
medium every three days. Cells were then washed with PBS, 
fixed with 4% paraformaldehyde and stained with Oil Red O 
(Sigma Aldrich) to detect lipid. 
Histological and Immunocytochemical Analysis 
Histological Analysis 
 The osteogenic-differentiated cells were fixed initially 
with 4% paraformaldehyde in PBS at pH 7.4 for 15 minutes. 
The mineralized matrix was evaluated by von Kossa stain-
ing. Cartilage matrix deposition by chondrogenic-differen- 
tiated cells cultured in six-well plates was identified by the 
staining of Alcian Blue. Adipogenic cells were detected us-
ing Oil red O staining to visualize the oil droplets. 
Immunocytochemical Analysis 
 Chondrogenic differentiation was also evaluated by 3-
dimensional pellet culture. The cell pellets were fixed in 4% 
paraformaldehyde and then embedded in paraffin blocks. 
Blocks were cut into 5-m sections. For immunocytochemi-
cal analysis, cell sections were incubated with 3% hydrogen 
peroxide (H2O2) for 15 min to eliminate endogenous peroxi-
dase activity. Non-specific protein binding in the sections 
was blocked by 10% swine serum (DakoCytomation, Bot-
any, NSW, Australia) in PBS containing 0.1% bovine serum 
albumin (BSA; Sigma Aldrich) and sodium azide (NaN3; 
Sigma Aldrich). Sections were incubated with optimal dilu-
tion (1: 10) of primary antibodies for collagen type II and 
aggrecan (Chemicon) overnight at 4 0C. Sections were then 
incubated with a biotinylated swine–anti-mouse, rabbit, goat 
secondary antibody (DAKO Multilink; DakoCytomation) for 
15 minutes and then incubated with horse radish peroxidase-
conjugated avidin-biotin complex (DAKO Multilink; Dako-
Cytomation) for 15 minutes. Antibody complexes were visu-
alized after the addition of a buffered diaminobenzidine 
(Sigma Aldrich) substrate for 3 minutes. The reaction was 
stopped by immersion and rinsing the sections in PBS. The 
sections were then counterstained with Mayer’s hematoxylin 
(Sigma Aldrich) for 15 seconds and were rinsed in tap water 
for 5 minutes. Finally, the sections were dehydrated in as-
cending concentrations of ethanol solutions, cleared in xy-
lene and mounted with coverslips using DePeX mounting 
medium (Labtek, Brendale, QLD, Australia). 
Total RNA Isolation and Reverse Transcriptase-Poly- 
merase Chain Reaction (RT-PCR) Analysis 
 Total RNA was extracted from 28 day cultures (cell 
monolayers and 3-D pellets) using Tri Reagent (Sigma Ald-
rich) as per the manufacturer’s protocol and total RNA con-
centration was determined spectrophotometrically. The 
mRNA was reverse transcribed to first strand cDNA from 1 
g RNA for a 20 l reverse transcription reaction using Su-
perScript III reverse transcriptase (200 units/l, Invitrogen) 
with Oligo dT as the primer. 
 Expression of the specific mRNAs relative to the os-
teogenic lineages [alkaline phosphatase (ALP), type I Colla-
gen (Col-I), osteopontin (OPN), osteocalcin (OCN)], chon-
drogenic lineages [type II collagen (Col-II), and aggrecan 
(AGG)] and adipogenic lineages [peroxisome proliferator-
activated receptor 2 (PPAR2), fatty acid binding protein 
(AP2)] were examined by RT-PCR. Beta-2 Microglobulin 
( 2 M) was used as a control for the RT-PCR analysis. PCR 
was performed using 2 l cDNA, 1 U of Red Taq DNA po-
lymerase (Sigma Aldrich) and 10 pM of each primer (Table 
1) in a 20 l reaction mixture for 31-35 cycles to make sure 
Table 1. Primers for RT-PCR 
Primers   Forward   Reverse Product Size 
Osteogenic Primers:  
ALP 5 TCAGAAGCTCAACACCAACG 3 5 TTGTACGTCTTGGAGAGGGC 3 180 
Col- I 5 CTTTGGAGCCAGCTTGGA 3 5 GTGGGCTTCCTGGTGA 3 450 
OPN 5  CCAAGTAAGTCCAACGAAAG 3 5 GGTGATGTCCTCGTCTGTA 3 347 
OCN 5 CACCGAGACACCATGAG 3 5 TGGAGAGGAGCAGAACTG 3 346 
Chondrogenic Primers  
Col- II 5 GGTGAAGAAGGCAAGAGA 3 5 CAGCACCTGTCTCACCA3  280 
AGG 5 AGACTTGGTGGGGTCAG 3 5 GATGTTTCCCCACTAGTG 3 450 
Adipogenic Primers  
PPAR 2 5 CTGTTGACTTCTCCAGCA 3 5 GTCAGCGGACTCTGGA 3 550 
AP2 5 TCAGTGTGAATGGGGATG 3 5 AAACTCTCGTGGAAGTG 3 241 
 2  5 CCCCCACTGAAAAAGATGAG 3 5 TCACTCAATCCAAATGCGGC 3 102 
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that amplification was in the linear range for each primer 
pair. Each cycle consisted of 94 0C of denaturation for 1 
minute, 53 0C of annealing for 30 seconds and 72 0C of ex-
tension for 30 seconds. Following PCR, the amplified line-
age specific transcripts were electrophoresed in 2% agarose 
gel to enable visualization of the PCR products. The relative 
density of PCR products was measured using NIH Image 
V1.62 to analyze one dimensional electrophoretic gel and the 
expression level of each gene was calculated relative to 
beta2-microglobulin.  
Statistical Analysis 
 Unless otherwise stated, all results were based on data 
generated from triplicate studies of each sample of seven 
BMSCs, hOB, and YCC samples, and five OBM samples. 
Statistics were analyzed using one-way ANOVA and SNK-q 
statistical tests from the statistical package SPSS v14 (Chi-
cago, IL). The significant difference was considered at 
p<0.05.  
RESULTS 
Growth and Morphology of BMSC and Tissue-Derived 
Cells 
 BMSC fractions from density gradient centrifugation 
failed to spread, migrate or proliferate when cultured in high 
glucose media (HG DMEM) containing 10% FBS. However, 
when cultured in low glucose media (LG DMEM), numerous 
fibroblast-like cells were observed in the culture. Therefore, 
BMSC fractions from density gradient centrifugation were 
cultured in low glucose media (LG DMEM) containing 
10%FC and numerous fibroblast-like cells were observed 
after 7 days in the culture. Subsequently, these cells formed 
colonies which expanded to form MSC-like fibroblastoid 
cells occupying the entire plastic surface of the culture ves-
sel. Initially, the isolated adherent BMSCs were observed as 
heterogeneous groups of cells and later became homogene-
ous as the cells continued to proliferate based on cell mor-
phology. The primary cultures were maintained for 12-16 
days before they were detached by trypsinization and subcul-
tured. Cells from the second passage (P2) demonstrated a 
fibroblast-like, spindle-shaped morphology when viewed 
under phase contrast microscopy (Fig 1A). All BMSC sam-
ples could be expanded over 24 population doublings (8 pas-
sages), but in the 8th passage (P8), the spindle or bipolar-
shaped BMSCs began to display a broadened, flat morphol-
ogy. The cells also showed a distinctive swirly pattern when 
confluent that was consistent with previous findings [41]. 
About 95-98% of the isolated BMSCs were phenotypically 
homogeneous when confluent, as determined by their fibro-
blastic shape. The results indicate that all of these bone mar-
row-derived cells have morphologic characteristics of MSCs. 
 Explant cultures from trabecular bone, alveolar bone and 
cartilage were maintained in HG DMEM supplemented with 
10% FCS and penicillin/streptomycin (Invitrogen). After one 
week of cultivation, hOBs, YCCs and OBMs also yielded 
numerous fibroblast-like cells (as shown in Fig. 1B, C, D) 
that subsequently expanded to occupy the whole plastic sur-
face of the culture vessel. Phase contrast microscopy also 
revealed similar BMSC-like swirly patterns of cell growth 
among the tissue derived-cells (data not shown). All these 
tissue-derived cells were able to be explanted over 24 popu-
lation doubling (8 passages). Furthermore, in contrast to 
other cell types, OBMs exhibited rapid proliferative potential 
and became 95% confluent within 3-4 days of passage (1:3 
split) when expanded in high glucose media, while other 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Morphology of primary cells cultured in their respective media for 2 weeks. (A) Bone marrow-derived MSCs in low glucose 
DMEM isolated by density gradient centrifugation; and (B) trabecular bone chip- derived cells (hOBs), (C) cartilage- derived cells (YCCs) 
and (D) alveolar bone-derived cells (OBMs) in high glucose DMEM (magnification = 200 times).  
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types of cells required 8-10 days to reach 95% confluence 
after passage (1:3 split). 
FACS Analysis 
 Immunophenotype analysis of BMSC and explant-
derived cells was determined using FACS. Flow cytometric 
analyses demonstrated that BMSCs and explant-derived cells 
similarly expressed typical MSC specific antigens CD29, 
CD90, CD105, CD166, and were negative for the early he-
matopoietic marker and lymphocytic markers CD34, CD45 
respectively (Fig. 2). 
In Vitro Differentiation Studies of BMSCs and the Tissue-
Derived Cells into Osteoblasts, Chondrocytes and Adipo-
cytes  
 To investigate and establish the differentiation potential, 
the passage 2 and passage 6 of various tissue-derived cells 
and BMSCs were placed at a density of 2.7 X 104 cells/ml in 
a six-well plate and cultured under appropriate conditions to 
induce lineage specific differentiation. Bone-derived, carti-
lage-derived and alveolar bone-derived explant cultures were 
assayed in parallel. For osteogenic differentiation, cells were 
cultured in monolayers in the presence of osteogenic sup-
plements and acquired an osteoblastic morphology with the 
deposition of mineralized extracellular matrix as demon-
strated with von Kossa staining (Fig. 3). No mineralized ma-
trix could be detected in the undifferentiated cultures, which 
were maintained in culture medium alone. Within 2 – 4 
weeks BMSCs showed gradual deposition of calcium nodule 
formation in the cell culture, which covered the entire vessel 
surface after four weeks. All tissue-derived cells exhibited an 
osteoblast phenotype with the detectable matrix mineraliza-
tion. However, the bone nodule size and number in tissue-
derived cells were much less than BMSCs in osteogenic cul-
ture. The osteoblastic phenotype was further assessed by 
measuring the expression of alkaline phosphatase (ALP), 
collagen I (Col I), osteopontin (OPN) and osteocalcin (OCN) 
using RT-PCR (Fig. 4A) in all samples. All these osteogenic 
markers were detectable in all four cell types during 2-4 
week osteogenic culture. Variation was detected in the 
mRNA expression level of these markers in each individual 
sample. For example in the sample presented in Fig. (4A), 
YCC showed less mRNA expression of Col-I and OPN and 
BMSCs showed less expression of OCN. However, no statis-
tically significant difference was found in these gene expres-
sion amount BMSC, hOB, YCC and OBM in 28 days of 
osteogenic induction, when all samples (n=7) were summa-
rized and normalized with the house keeping gene (2M) 
(p>0.05) (Fig. 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Analysis of different cell preparations of MSCs, hOBs, OBMs and YCCs for the expression of surface antigens by flow cytometry. 
Cells were cultured for 5 passages, harvested and labelled with antibodies against human antigens CD166, CD105, CD90, CD45, CD34 and 
CD29 indicating both positive for CD 166, CD105, CD29, CD90 and negative for CD34 and CD45. 
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 Chondrogenic differentiation in monolayers was pro-
moted in early passages of all samples subjected to serum-
free chondrogenic medium containing TGF3. Under this 
condition the tissue-derived cells and the BMSCs lost some 
of their fibroblastic morphology and acquired the polygonal 
or cuboidal morphology of a typical chondrocyte (Fig. 3). 
YCC, along with the BMSCs, exhibited a typical chondro-
cyte phenotype, but hOB and OBM showed less polygonal 
morphological changes in 4 weeks chondrogenic culture 
(Fig. 3). After 28 days the chondrocytic phenotype was fur-
ther confirmed by the expression of collagen type II (Col II) 
and aggrecan (AGG) using RT-PCR (Fig. 4B) in all 
differentiated BMSCs and tissue-derived cells, with no 
expression in the controls (data not shown). A significantly 
lower expression of Col II and AGG in OBM was observed 
in comparison to YCC (p<0.05).  
 Chondrogenic differentiation was further evaluated in 
micromass culture for 3-4 weeks in serum-free chondrogenic 
medium supplemented with TGF3. Sections (5 m) of 3-
week old cultures were processed for histological analysis. 
Within the sections, depositions of sulphated proteoglycans 
were stained blue by Alcian Blue (Fig. 5A). Immunocyto-
chemical studies also revealed that the major components of 
the extracellular matrix (ECM) in the chondrogenic micro-
mass cultures were Col II and AGG as shown by the brown 
color in the sections (Fig. 5A). RT-PCR results also con-
firmed the expression of Col II and AGG mRNA as observed 
in immunocytochemical analysis. There was less expression 
of Col-II and AGG in BMSCs and hOB pellet cultures com-
pared with YCC (Fig. 5B). However, no significant differ-
ence in both Col-II and AGG expression amongst BMSC, 
hOB and YCC in chondrogenic micromass culture, when all 
samples (n=7) were summarized and normalized to the house 
keeping gene (2M) (p>0.05) (Fig. 5). 
 The adipogenic potential of early passages of BMSCs 
and explant tissue-derived cells was assayed after inducing 
adipogenic differentiation. After 4 week of induction, the 
cell morphology changed and accumulation of lipid rich 
vacuoles were observed as visualized by oil red O staining 
(Fig. 3). OBM showed the lowest level of staining for lipid. 
However, after 4 weeks of induction the adipocyte specific 
peroxisome proliferators-activated receptor 2 (PPAR2) and 
fatty acid binding protein (AP2) were determined by RT-
PCR (Fig. 4C) and found to be expressed in BMSCs and all 
tissue-derived cells (Fig. 4). 
DISCUSSION 
 Despite the fact that bone marrow aspirates have been 
considered to be the most accessible and enriched source of 
MSCs [18] autologous bone marrow procurement has limita-
tions. For reasons that are not apparent, there have been vari-
able problems in isolating BMSCs. The number and prolif-
erative capacity of BMSCs depends on donor age, disease 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Histological analyses by phase contrast microscopy in bone marrow derived MSCs (BMSCs) and tissue-derived cells-trabecular 
bone (hOBs), cartilage cell (YCCs) and alveolar bone cells (OBMs). Cells in monolayer cultures in six-well plates were tested for their abil-
ity to differentiate in vitro to multiple lineages for 28 days. Osteogenesis was indicated by the calcium deposition producing a mineralized 
matrix that was detected by von Kossa staining. Chondrogenesis was shown by staining with Alcian Blue. Adipogenesis was indicated by the 
accumulation of lipid vacuoles that stained with Oil Red O. In untreated cell cultures there was an absence of such phenotypes (magnifica-
tion = 200 times). 
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history and the volume of marrow aspirates obtained [19, 
32]. MSCs residing in diverse mature host tissues have re-
cently been recognized [28, 29], hence potentially providing 
alternative sources of MSCs for both basic research and 
clinical application. In view of this, we compared and char-
acterized tissue-derived (trabecular bone, cartilage and al-
veolar bone) MSCs using explant culture method with the 
properties of bone marrow-derived MSCs to evaluate the 
differential potential of these cells. This study demonstrated 
that the MSCs harvested from explant culture of committed 
tissues shared a commonality with bone marrow-derived 
cells in terms of morphology and immunophenotype. The 
expression of molecular differentiation markers and their 
phenotypic potential to differentiate into multiple mesen-
chymal cell lineages in vitro were demonstrated in tissue-
derived explant cultures. Thus, cells from tissue-derived ex-
plant cultures possessed certain degree of typical stem cell 
properties such as being multipotent and able to self renew.  
 In our experiments the tissue-derived cells were isolated 
through explant cultures without treating the tissues with any 
external enzymatic digestion as reported by others [17]. This 
explant culture method isolated the cells from cartilage and 
bone depending on the cell potential to migrate out of the 
bone and cartilage. These cells showed fibroblastic spindle 
shape similar to BMSCs and expressed typical MSC cell 
surface markers, negative for CD45 and CD34 and positive 
for CD29, CD90, CD166, and CD105 (SH2) [42]. Although 
it is well know that bone marrow-derived MSCs have great 
proliferation capacity, in the present study the expansion 
ability of tissue-derived cells showed similarly to that of 
BMSCs. Tissue-derived and marrow-derived MSCs were 
both able to be explanted for at least 24 population doublings 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). RT-PCR analyses of mRNA expression of lineage specific genes in osteogenic, chondrogenic and adipogenic cultures in bone mar-
row-derived MSCs and tissue-derived cells (hOBs, YCCs and OBMs). A. Under osteogenic conditions cells expressed the osteoblast related 
genes; alkaline phosphatase (ALP: 180 bps), collagen I (Col -I: 450 bps), osteopontin (OPN: 347 bps) and osteocalcin (OCN: 346 bps). B. 
Chondrogenic differentiation of monolayers with TGF-3 expressed cartilage specific genes- collagen II (Col-II: 280 bps), and aggrecan 
(AGG: 450 bps). C. The cells treated with adipogenic supplements expressed the adipocyte specific genes peroxisome proliferator-activated 
receptor (PPAR 2: 550 bps) and fatty acid binding protein (AP2: 241 bps). In all these PCR reactions, -2-microglobulin (2M: 102 bps) 
was used as a control for RT-PCR. The graph shows the relative expression level of each gene in relation to the expression of -2-
microglobulin. 
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(8 passages) with similar kinetics of cell growth. The highest 
self-renewal capacity was noted in OBM, which may in part 
be explained by the fact that these cells were derived from 
alveolar bone specimens from patients with a younger age. 
These data, in turn, suggested that the cells that migrated out 
of the tissue explants had similar characteristics in culture to 
bone marrow-derived MSCs.  
 The multilineage differentiation capacity of the tissue-
derived cells was assessed by the phenotypical expression of 
extracellular matrix and differentiation genes relative to 
mesenchymal cell lineages: osteogenic, chondrogenic and 
adipogenic. In general tissue-derived cells were able to be 
differentiated into osteoblasts, chondrocytes and adipocytes 
because the extracellular matrix and differentiation genes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (5). Chondrogenesis was determined in micromass pellet cultures using bone marrow-derived MSCs, tissue-derived cells (hOBs and 
YCCs). Cells (500,000) were subjected to low-speed (600g) centrifugation and the cell mass was cultured in defined chondrogenic media 
with TGF-3 for 21 days. Chondrogenesis was evaluated by the accumulation of proteoglycans staining with Alcian Blue (5A, magnification 
= 200 times). Micromass pellet cultures showing morphological changes were subject to immunohistological analysis with an antibody spe-
cific for Col-II and AGG (5A, magnification = 200 times). In control sections there was an absence of such phenotypes. All samples were 
cultured in pellet format for 28 days in the presence of TGF-3 prior to recovery of total RNA and PCR analysis. 3D-Chondrogenic differen-
tiation resulted in cells that expressed cartilage specific genes (Col-II and AGG) (Fig. 5B). -2-microglobulin is used as a control for RT-
PCR. The graph shows the relative expression level of each gene in relation to the expression of -2-microglobulin. 
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typical for differentiated osteogenic, chondrogenic, and adi-
pogenic cells have been detected. However, histologically 
greater calcium deposition and hence greater osteogenic dif-
ferentiation potential was observed with the BMSCs com-
pared to the tissue-derived MSCs as detected by von Kossa 
stain. Moreover, cells derived from cartilage showed a ten-
dency of less mRNA expression of Col-I and OPN compared 
with cells derived from bone in the osteogenic condition. 
Interestingly OBM showed lower differentiation capacity 
into chondrocytes and adipocytes despite OBM was derived 
from younger aged patients compared with other tissue de-
rived cells, which indicates that age may not be the only de-
terminant of differentiation capacity of tissue-derived cells. 
We have also demonstrated that tissue-derived cells can be 
cultured in high density pellet culture in a serum-free chemi-
cally defined medium containing TGF 3; a property shared 
with BMSCs [36, 43, 44]. The mass of the tissue increased 
over a period of 3 weeks as shown for the BMSCs. The 
deposition of cartilage matrix such as proteoglycans was 
detected in the mass culture of tissue-derived cells. Further-
more, RT-PCR analysis of cells in the micromass pellet re-
vealed the expression of the chondrogenic specific marker 
genes Col II, and AGG, demonstrating the cartilage pheno-
type of these pellets in the chondrogenic media. These data 
regarding mesenchymal differentiation lead us to suggest 
that tissue-derived cells retain some degree of plasticity and 
their differentiation capacity is more dependent on their mi-
croenvironment and less dependent on their primitive status 
[32, 45].  
 In summary, our data indicates that MSCs can be sourced 
not only from bone marrow, but also from other readily 
available sources like trabecular bone, alveolar bone and 
cartilage via explant culture. However, mesenchymal stromal 
cells isolated from other sources are less potent than bone 
marrow derived MSCs. 
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